Literature DB >> 33513830

Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice.

Yu-Te Chou1,2, Tze-Tze Liu2,3, Ueng-Cheng Yang2,4, Chia-Chang Huang2,5,6, Chih-Wei Liu1,2,6, Shiang-Fen Huang2,7, Tzu-Hao Li2,6,8, Hsuan-Miao Liu9, Ming-Wei Lin2,10, Ying-Ying Yang2,5,6,11, Tzung-Yan Lee9, Yi-Hsiang Huang1,2,10,11, Ming-Chih Hou1,2, Han-Chieh Lin2,11.   

Abstract

In advanced cirrhosis, the TNFα-mediated intestinal inflammation and bacteria dysbiosis are involved in the development of inflammation and vasoconstriction-related renal dysfunction. In colitis and acute kidney injury models, activation of SIRT1 attenuates the TNFα-mediated intestinal and renal abnormalities. This study explores the impacts of intestinal SIRT1 deficiency and TNFα-mediated intestinal abnormalities on the development of cirrhosis-related renal dysfunction. Systemic and renal hemodynamics, intestinal dysbiosis [cirrhosis dysbiosis ratio (CDR) as marker of dysbiosis], and direct renal vasoconstrictive response (renal vascular resistance (RVR) and glomerular filtration rate (GFR)) to cumulative doses of TNFα were measured in bile duct ligated (BDL)-cirrhotic ascitic mice. In SIRT1IEC-KO-BDL-ascitic mice, the worsening of intestinal dysbiosis exacerbates intestinal inflammation/barrier dysfunction, the upregulation of the expressions of intestinal/renal TNFα-related pathogenic signals, higher TNFα-induced increase in RVR, and decrease in GFR in perfused kidney. In intestinal SIRT1 knockout groups, the positive correlations were identified between intestinal SIRT1 activity and CDR. Particularly, the negative correlations were identified between CDR and RVR, with the positive correlation between CDR and GFR. In mice with advanced cirrhosis, the expression of intestinal SIRT1 is involved in the linkage between intestinal dysbiosis and vasoconstriction/hypoperfusion-related renal dysfunction through the crosstalk between intestinal/renal TNFα-related pathogenic inflammatory signals.

Entities:  

Keywords:  NAD-dependent deacetylase sirtuin-1 (SIRT1); cirrhotic ascites; intestinal barrier dysfunction; intestinal dysbiosis; renal dysfunction; tumor necrosis factor-α (TNFα)

Mesh:

Substances:

Year:  2021        PMID: 33513830      PMCID: PMC7865325          DOI: 10.3390/ijms22031233

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  55 in total

1.  Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.

Authors:  Peng Chen; Peter Stärkel; Jerrold R Turner; Samuel B Ho; Bernd Schnabl
Journal:  Hepatology       Date:  2015-01-30       Impact factor: 17.425

2.  Tumor necrosis factor-α receptor type 1, not type 2, mediates its acute responses in the kidney.

Authors:  Alexander Castillo; M Toriqul Islam; Minolfa C Prieto; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-28

3.  Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury.

Authors:  Joseph H Holthoff; Zhen Wang; Kathryn A Seely; Neriman Gokden; Philip R Mayeux
Journal:  Kidney Int       Date:  2011-10-05       Impact factor: 10.612

4.  Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro.

Authors:  Jiangnan Zhang; Ran Bi; Qiang Meng; Changyuan Wang; Xiaokui Huo; Zhihao Liu; Chong Wang; Pengyuan Sun; Huijun Sun; Xiaodong Ma; Jingjing Wu; Kexin Liu
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

5.  Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.

Authors:  R D Zipser; G H Radvan; I J Kronborg; R Duke; T E Little
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

6.  Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Authors:  Constanze Buhrmann; Franziska Busch; Parviz Shayan; Mehdi Shakibaei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

7.  Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model.

Authors:  Mar Larrosa; María Josefa Yañéz-Gascón; María Victoria Selma; Antonio González-Sarrías; Simona Toti; José Joaquín Cerón; Francisco Tomás-Barberán; Piero Dolara; Juan Carlos Espín
Journal:  J Agric Food Chem       Date:  2009-03-25       Impact factor: 5.279

8.  Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function.

Authors:  Shuyun Liu; Meng Zhao; Yijie Zhou; Chengshi Wang; Yujia Yuan; Lan Li; William Bresette; Younan Chen; Jingqiu Cheng; Yanrong Lu; Jingping Liu
Journal:  Phytomedicine       Date:  2018-12-17       Impact factor: 5.340

9.  Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.

Authors:  Weiwei Jiang; Na Wu; Xuemei Wang; Yujing Chi; Yuanyuan Zhang; Xinyun Qiu; Ying Hu; Jing Li; Yulan Liu
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

10.  CoNet app: inference of biological association networks using Cytoscape.

Authors:  Karoline Faust; Jeroen Raes
Journal:  F1000Res       Date:  2016-06-27
View more
  2 in total

1.  Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.

Authors:  Szu-Yu Liu; Chia-Chang Huang; Shiang-Fen Huang; Tsai-Ling Liao; Nai-Rong Kuo; Ying-Ying Yang; Tzu-Hao Li; Chih-Wei Liu; Ming-Chih Hou; Han-Chieh Lin
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

Review 2.  The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Authors:  Xun Zhou; Hui Chen; Yingfeng Shi; Xiaoyan Ma; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.